These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 16113663

  • 1. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Ito JI, Chandrasekar PH, Hooshmand-Rad R.
    Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
    [Abstract] [Full Text] [Related]

  • 2. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
    Chandrasekar PH, Ito JI.
    Clin Infect Dis; 2005 May 01; 40 Suppl 6():S392-400. PubMed ID: 15809925
    [Abstract] [Full Text] [Related]

  • 3. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD, Dodds Ashley ES, Addison RM, Alspaugh JA, Chao NJ, Perfect JR.
    Transpl Infect Dis; 2006 Mar 01; 8(1):13-20. PubMed ID: 16623816
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR.
    Bone Marrow Transplant; 1997 Feb 01; 19(4):343-7. PubMed ID: 9051244
    [Abstract] [Full Text] [Related]

  • 5. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy.
    Hachem RY, Boktour MR, Hanna HA, Husni RN, Torres HA, Afif C, Kontoyiannis DP, Raad II.
    Cancer; 2008 Mar 15; 112(6):1282-7. PubMed ID: 18224662
    [Abstract] [Full Text] [Related]

  • 6. Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
    Roy V, Ali LI, Carter TH, Selby GB.
    J Infect; 2000 Nov 15; 41(3):273-5. PubMed ID: 11120619
    [Abstract] [Full Text] [Related]

  • 7. Study of renal safety in amphotericin B lipid complex-treated patients.
    Alexander BD, Wingard JR.
    Clin Infect Dis; 2005 May 01; 40 Suppl 6():S414-21. PubMed ID: 15809928
    [Abstract] [Full Text] [Related]

  • 8. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
    Mehta J, Kelsey S, Chu P, Powles R, Hazel D, Riley U, Evans C, Newland A, Treleaven J, Singhal S.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):39-43. PubMed ID: 9232254
    [Abstract] [Full Text] [Related]

  • 9. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
    Perfect JR.
    Clin Infect Dis; 2005 May 01; 40 Suppl 6():S401-8. PubMed ID: 15809926
    [Abstract] [Full Text] [Related]

  • 10. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
    Linden PK, Coley K, Fontes P, Fung JJ, Kusne S.
    Clin Infect Dis; 2003 Jul 01; 37(1):17-25. PubMed ID: 12830404
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
    Hooshmand-Rad R, Reed MD, Chu A, Gotz V, Morris JA, Weinberg J, Dominguez EA.
    Clin Ther; 2004 Oct 01; 26(10):1652-62. PubMed ID: 15598482
    [Abstract] [Full Text] [Related]

  • 13. Successful use of amphotericin B lipid complex in the treatment of cryptococcosis.
    Baddour LM, Perfect JR, Ostrosky-Zeichner L.
    Clin Infect Dis; 2005 May 01; 40 Suppl 6():S409-13. PubMed ID: 15809927
    [Abstract] [Full Text] [Related]

  • 14. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
    Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RH, Patterson TF, Pottage JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS.
    Clin Infect Dis; 1996 Feb 01; 22(2):315-21. PubMed ID: 8838189
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of invasive zygomycosis infections in renal transplant recipients.
    Forrest GN, Mankes K.
    Transpl Infect Dis; 2007 Jun 01; 9(2):161-4. PubMed ID: 17462005
    [Abstract] [Full Text] [Related]

  • 16. Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
    Jansen J, Akard LP, Wack MF, Thompson JM, Dugan MJ, Leslie JK, Mattison R.
    Mycoses; 2006 Sep 01; 49(5):397-404. PubMed ID: 16922792
    [Abstract] [Full Text] [Related]

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 01; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 18. The experience is CLEAR.
    Chandrasekar P.
    Int J Antimicrob Agents; 2006 Jun 01; 27 Suppl 1():31-5. PubMed ID: 16707248
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.